Skip to content

Quantitative assessment of scalp cooling effect in chemotherapy induce alopecia

Quantitative assessment of scalp cooling in chemotherapy induce alopecia : A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171106002
Enrollment
40
Registered
2017-11-06
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer breast cancer scalp cooling alopecia chemotherapy

Interventions

Scalp cooling is applied for this arm in every cycle of chemotherapy at least 4 consecutive cycles. ,Scalp cooling is NOT applied for this arm in every cycle of chemotherapy at least 4 consecutive cyc
Scalp cooling,Scalp cooling

Sponsors

Ratchadapiseksompotch Fund (Pending)
Lead Sponsor
Ratchadapiseksompotch Fund (Pending)
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-70 years old 2.CA breast patient who recieve one of the following chemotherapy regimen : oxorubicin cyclophosphamide or taxane-based regimen as neoadjuvant chemotherapy or adjuvant chemotherapy 3. At least 4 cycles of chemotherapy

Exclusion criteria

Exclusion criteria: 1. History of previous chemotherapy treatment 2. Alopecia at least gr.I before receiving chemotherapy 3. History of migraine, hypothyroid, hepatitis, uncontrolled diabetes, cold intolerance, cryoglobulinemia, cryofibrinogenemia or cold agglutinin disease 4. History of iron deficiency anemia 5. History of oral contraceptive pill or hormone replacement therpary 6. History of psychological disorder diagnosed by psychiatrist 7. History of scalp disease 8. History of previous alopecia treatmenr 9. History of hair transplantation

Design outcomes

Primary

MeasureTime frame
Hair count after each chemotherapy cycle Hair scope

Secondary

MeasureTime frame
Hair mass index after each chemotherapy cycle HairCheck instrument,Breast Cancer-Specific Quality of Life Questionnaire Items after each chemotherapy cycle Questionnaire,Hair follicle caspase-8, apoptotic (TUNEL+) cell, proliferation (Ki-67+) cell after 1 cycle chemotherapy biopsy and immunohistochemistry

Countries

thailand

Contacts

Public Contactsarun thongvitokomarn

Unaffiliated

topth@hotmail.com+66868952954

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026